ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,983.98
0.90%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Savencia SA (SAVE) Quote

Savencia SA

Savencia SA (SAVE)

Pinnacle Fund Services Limited
Savannah Energy Plc
Spirit Airlines Inc
52.40
-0.40
(-0.76%)
Closed April 27 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
52.40
Bid
52.00
Ask
52.80
Volume
1,095
52.00 Day's Range 53.00
49.30 52 Week Range 63.60
Market Cap
735.326M
Previous Close
52.80
Open
52.40
Last Trade
3
@
52.4
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,183
Shares Outstanding
14,032,930
Dividend Yield
2.48%
PE Ratio
7.62
Earnings Per Share (EPS)
6.88
Revenue
6.79B
Net Profit
96.48M

About Savencia SA

Sector
Nat, Process, Imitatn Cheese
Industry
Dairy Products
Website
www.savencia-fromagedairy.com
Headquarters
Versailles, Yvelines, Fra
Founded
1956
Savencia SA is listed in the Nat, Process, Imitatn Cheese sector of the Euronext with ticker SAVE. The last closing price for Savencia was 52.80 €. Over the last year, Savencia shares have traded in a share price range of 49.30 € to 63.60 €.

Savencia currently has 14,032,930 shares outstanding. The market capitalization of Savencia is 735.33 € million. Savencia has a price to earnings ratio (PE ratio) of 7.62.

SAVE Latest News

More News

SAVENCIA : Rapport sur le Gouvernement d'Entreprise

SAVENCIA : Rapport sur le Gouvernement d'Entreprise SAVENCIA : Rapport sur le Gouvernement d'Entreprise 2023 Pièce jointe Rapport sur le Gouvernement d'entreprise Savencia SA...

April 26 2024
GlobeNewswire Inc.

Communiqué de mise à disposition du Rapport sur le Gouvernement d’Entreprise relatif à l’exercice 2023

Communiqué de mise à disposition du Rapport sur le Gouvernement d’Entreprise relatif à l’exercice 2023 Communiqué de mise à disposition duRapport sur le Gouvernement d’Entreprise relatif à...

April 26 2024
GlobeNewswire Inc.

Savencia : Descriptif du programme de rachat par SAVENCIA SA de ses propres actions

Savencia : Descriptif du programme de rachat par SAVENCIA SA de ses propres actions SAVENCIA SASociété Anonymeau capital de 14 032 930 eurosSiège Social : 42 rue Rieussec - 78220 VIROFLAY847...

April 26 2024
GlobeNewswire Inc.

Savencia : Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023

Savencia : Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2023 La société...

April 26 2024
GlobeNewswire Inc.

Savencia : Activité du 1er trimestre 2024

Savencia : Activité du 1er trimestre 2024          Jeudi 25 avril 2024  COMMUNIQUE DE PRESSE : Activité du 1er trimestre 2024   Progression du chiffre d’affaires de +1,6%    Chiffres clés en...

April 25 2024
GlobeNewswire Inc.

Savencia : Activity of the 1st quarter 2024

Savencia : Activity of the 1st quarter 2024          Thursday, April 25, 2024  PRESS RELEASE: Activity of the 1st quarter 2024   Sales growth of +1.6%   Consolidated data in €M   31/03/24  ...

April 25 2024
GlobeNewswire Inc.

Communiqué de mise a disposition des Documents pour l'Assemblée Générale

Communiqué de mise a disposition des Documents pour l'Assemblée Générale SAVENCIA SA informe ses actionnaires qu’ils sont convoqués en Assemblée Générale Mixte (Ordinaire et...

April 05 2024
GlobeNewswire Inc.

SAVENCIA FROMAGE & DAIRY: 2023 annual financials- Erratum

SAVENCIA FROMAGE & DAIRY: 2023 annual financials- Erratum                         Thursday, March 7, 2024 PRESS RELEASE: 2023 annual financials Sales growth of +3.7% Current operating...

March 08 2024
GlobeNewswire Inc.

SAVENCIA FROMAGE & DAIRY : Comptes annuels 2023

SAVENCIA FROMAGE & DAIRY : Comptes annuels 2023         Jeudi 07 mars 2024 COMMUNIQUE DE PRESSE : Comptes annuels 2023 Une progression du chiffre d’affaires de +3,7% Un résultat...

March 07 2024
GlobeNewswire Inc.

SAVENCIA: 2023 annual sales

SAVENCIA: 2023 annual sales Thursday 8 February 2024 PRESS RELEASE: 2023 annual sales Reported sales growth of +3.7% over the year 2023, despite a decline of -3.7% in the fourth quarter...

February 08 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.61.158301158351.853.451.8111253.1694964DE
411.9455252918351.453.449.3135051.75549245DE
12-1-1.8726591760353.454.649.3118351.98320608DE
26-2-3.6764705882454.456.649.3291654.65419516DE
52-8.8-14.379084967361.263.649.3188455.1103323DE
156-21.6-29.18918918927475.649.3238460.33578091DE
260-15-22.255192878367.478.245.1231959.43748378DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
Zilla Zilla 5 minutes ago
Almost another year later and 88.7% of BLCO is still with BHC almost 2 years after the IPO just before the ER...
Currently BLCO is 14.79 with less than 5% short interest...10.5% Inst owned...
BHC is @ 8.71 72% inst/owned about 12% short interest...
Norwich lost in court recentl
BHC BLCO
newmedman newmedman 7 minutes ago
I thought he might have had a little more zip. Honestly, I don't know if he's ever done stand up before, even in a limited capacity but if it was the gong show, he'd be getting the hook.

His jokes were funny.. but like janice said, the deadpan delivery was not appealing.
RainMaker2213 RainMaker2213 7 minutes ago
https://www.cnbc.com/amp/2024/04/26/anglo-american-rejects-bhps-39-billion-takeover-bid-to-form-mining-juggernaut.html
LBRMF
Susie924 Susie924 9 minutes ago
https://x.com/EricColumbus/status/1784420260579266779
Acme Investments Acme Investments 10 minutes ago
Very interesting!! Since the otc is not recognizing the value of his coins he's looking for another way to monetize them!! Smart 🧠 man!!
BMCS
Vexari Vexari 11 minutes ago
Makes one wonder

www.youtube.com/watch?v=CPSkNFODVRE If we all call the tune

Then the piper will lead us to reason
And a new day will dawn
For those who stand long

And the forests will echo with laughter

When all are one an
PFE
dstock07734 dstock07734 11 minutes ago
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
https://classic.clinicaltrials.gov/ct2/show/NCT01368107

Abstract CT333: Elypse-7: A randomized, placebo-controlled, Phase 2a ev
NWBO
zerosnoop zerosnoop 12 minutes ago
But wait, according to the “experts”, I thought this was supposed to be just a “simple leak test” ? Wonder why they would need to run the device at 40KV for a “simple leak test?” I guess we can also throw the “going against the laws of mother nature” claim out the window as well (I still laugh at th
QSEP
Roman516 Roman516 12 minutes ago
More deception tactics, but the real fact is that OS data in the golden results compared to the PFS statistical guess data. The OS data is what matters.
NWBO
mzasif mzasif 13 minutes ago
Nice! If the Q1 is good which are all hoping it will be... then my shares will transfer from back pocket to deep pockets until Q2 and Q3 comes out. But somewhere in this waiting process I will take my original investment out and ride on free shares until we hit cents/dollars.

All the
BLEG
nowwhat2 nowwhat2 15 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/4/27/ykqflbtc_444_26_15d_1015am_CERTAIN_DEATH_LINE_ZONE.jpg


https://investorshub.advfn.com/uimage/uploads/2024/4/27/jfggjbtc_444_27_15d_630pm_w_26_death_zone_1015.jpg






At w
BTCUSD
zerosnoop zerosnoop 15 minutes ago
UPDATED. More "INSIDER BUYING". Below is a recap of all the RECENT "INSIDER BUYING" by QS directors. This includes the RECENT $275,000 investment by the uncompensated ceo Kyte. The list CONTINUES to grow & grow

https://ir.qsenergy.com/all-sec-filings/content/0001683168-24-000913/owner
QSEP
zerosnoop zerosnoop 16 minutes ago
In its most extensive testing during this deployment, the AOT was operated under full-scale commercial operating conditions over a two-day period. Operations were overseen by the pipeline operator and QS Energy engineers, while engineers from ATS RheoSystems, a division of the CANNON Instrument Comp
QSEP
zerosnoop zerosnoop 17 minutes ago
we are proud to report that the AOT works at a full voltage of 40KV, well beyond the treatment field.
QSEP
varmit varmit 17 minutes ago
I don’t understand these .00001/.00005/.000001 trades even though I have gotten filled on them .

My order was to buy 100 million @.0001
So why would any insane idiot not take my $10,000 and issue my shares

No they sell to me for .00001 50 million and
T
RNVA
The Man With No Name The Man With No Name 18 minutes ago
The process will probably take more than a year. Not happening under Biden, like I said over a year ago.

I doubt anything will happen for another 2 years.
FNMA
zerosnoop zerosnoop 18 minutes ago
We believe QS Energy’s technologies will enable the petroleum industry to gain key value advantages boosting profit, while satisfying the needs of regulatory bodies at the same time. Key players in the pipeline industry continue to demonstrate interest in our technologies.
QSEP
newmedman newmedman 18 minutes ago
I'm not sure. The thread goes off in many directions and I might have posted it prematurely. I just thought it was a good catch. Especially if you take notice of the assault rifle he was carrying too.

Hell, if I tried that on a beach out here I'd probably be posting from my
zerosnoop zerosnoop 19 minutes ago
Our primary goal is to provide the oil industry with a cost-effective method by which to increase the number of barrels of oil able to be transported per day through the industry’s existing and newly built pipelines. The greatest impact on oil transport volume may be realized through reductions in p
QSEP
jsw10011 jsw10011 19 minutes ago
Certainly possible. It’s happened before with this ticker
NWGC
zerosnoop zerosnoop 19 minutes ago
After that achievement we evaluated, reworked, and finally retested AOT to commercial viability.
QSEP
OMOLIVES OMOLIVES 20 minutes ago
Happy Weekend! A little joy from the past.....all eleven minutes:

https://www.youtube.com/watch?v=nx_GIji9EGw
zerosnoop zerosnoop 20 minutes ago
Our current and primary product portfolio is dedicated to the crude oil production and transportation marketplace, with a specifically targeted product offering for enhancing the flow-assurance parameters of new and existing pipeline gathering and transmission systems.
QSEP

Your Recent History

EU
SAVE
Savencia
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved